Abbott Starts TriClip Study Amid Rising Competition for Heart Valve Repair

Abbott starts TriClip study amid rising competition for heart valve repair

Facing competition from Edwards, Abbott is studying TriClip’s real-world safety and performance in about 1,000 patients.

Abbott begins five year TriClip evidence study

Abbott has begun a five year post market study of its TriClip transcatheter valve repair system, enrolling the first participant at Hospital Clínic de Barcelona. The TREAT TR study is expected to include approximately 1,000 people at up to 100 sites across Europe, the United States, and Canada. It will assess safety and performance during routine clinical use, extending the evidence available from earlier controlled trials. Participants will be …

TriClip patients to be followed for five years in post-market study

Triclip Abbott has initiated the TREAT TR post-market study of the TriClip transcatheter edge-to-edge repair (TEER) system for the treatment of tricuspid regurgitation (TR). The study is designed to evaluate the safety and performance of TriClip in a real-world setting and build on existing evidence concerning the safety and efficacy of the device in addressing TR. The first enrolment in the TREAT TR study occurred at Hospital Clínic de Barcelon…

Abbott begins TREAT TR study to assess TriClip for leaky heart valve

Abbott has begun the TREAT TR study, to assess the safety and performance of its TriClip TEER system for patients with TR, also referred to as a leaky tricuspid valve.The post Abbott begins TREAT TR study to assess TriClip for leaky heart valve appeared first on Hospital Management.

Abbott Initiates TREAT TR Postmarket Study of the TriClip TEER System

July 28, 2026—Abbott announced it has initiated the TREAT TR postmarket study of the company’s TriClip transcatheter edge-to-edge repair (TEER) system for the treatment of tricuspid regurgitation (TR). The first patient in the study was enrolled by Xavier Freixa, MD, and his cardiac team at Hospital Clínic de Barcelona in Barcelona, Spain. According to Abbott, the prospective TREAT TR study is designed to evaluate the safety and performance of T…